Figure 3From: Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?Changes of FEV 1 before and during sirolimus therapy. Serial individual values of FEV1 (forced expiratory volume in 1 second) before and during sirolimus therapy in ten patients.Back to article page